FASLODEX


Solution for Injection
scheduling status
S4
registration number
A38/21.12/0656
What FASLODEX contains
Fulvestrant.
other ingredients
benzyl alcohol benzyl benzoate refined castor oil ethanol (10 % m/v).
Therapeutic classification
Endocrine therapy (L02A).
© 2026 SAHPRA. ALL RIGHTS RESERVED